<DOC>
	<DOC>NCT00779246</DOC>
	<brief_summary>This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).</brief_summary>
	<brief_title>Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus &amp; Other Hospital Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>All patients admitted to the medical intensive care unit (ICU) are eligible for inclusion Patient refusal Contraindication to nasal swabbing (arm 1) Allergy/sensitivity to chlorhexidine gluconate (CHG) (arm 2)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Methicillin resistance</keyword>
	<keyword>Infection control</keyword>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>Cross infection</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Chlorhexidine</keyword>
</DOC>